858
Views
4
CrossRef citations to date
0
Altmetric
Review

Advances in pharmacotherapeutic management of common skin diseases in neonates and infants

, , , &
Pages 717-725 | Received 10 Jan 2017, Accepted 03 Apr 2017, Published online: 21 Apr 2017

References

  • Kakande B, Gumedze F, Hlela C, et al. Focus on the top ten diagnoses could reduce pediatric dermatology referrals. Pediatr Dermatol. 2016 Jan-Feb;33(1):99–102.
  • Wassef M, Biei F, Adams D, et al. Vascular anomalies classification: recommendations form the international society for the study of vascular anomalies. Pediatrics. 2015 Jul;136(1):e203–14.
  • Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics. 1976 Aug;58(2):218–222.
  • Alper JC, Holmes LB. The incidence and significance of birthmarks in a cohort of 4,641 newborns. Pediatr Dermatol. 1983 Jul;1(1):58–68.
  • Chang LC, Haggstrom AN, Drolet BA, et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics. 2008 Aug;122(2):360–367.
  • Léauté-Labrèze C, Prey S, Ezzedine K. Infantile haemangioma: part I. Pathophysiology, epidemiology, clinical features, life cycle and associated structural abnormalities. J Eur Acad Dermatol Venereol. 2011 Nov;25(11):1245–1253.
  • Payne MM, Moyer F, Marcks KM, et al. The precursor to the hemangioma. Plast Reconstr Surg. 1966;38:64–67.
  • Maguiness S, Uihlein LC, Liang MG, et al. Rapidly involuting congenital hemangioma with fetal involution. Pediatr Dermatol. 2015 May-Jun;32(3):321–326.
  • Suh KY, Frieden IJ. Infantile hemangiomas with minimal or arrested growth: a retrospective case series. Arch Dermatol. 2010 Sep;146(9):971–976.
  • Nasseri E, Piram M, McCuaig CC, et al. Partially involuting congenital hemangiomas: a report of 8 cases and review of the literature. J Am Acad Dermatol. 2014 Jan;70(1):75–79.
  • Frieden IJ, Reese V, Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities. Arch Dermatol. 1996 Mar;132(3):307–311.
  • Girard C, Bigorre M, Guillot B, et al. PELVIS syndrome. Arch Dermatol. 2006 Jul;142(7):884–888.
  • Ovadia SA, Landi DC, Cohen ER, et al. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis. Ann Plastsurg. 2015 Feb;74(2):256–262.
  • Garzon MC, Lucky AW, Hawrot A, et al. Ultrapotent topical corticosteroid treatment of hemangiomas of infancy. J Am Acaddermatol. 2005 Feb;52(2):281–286.
  • Czernik A, Bystryn JC. Does imiquimod work in infantile hemangiomas? J Am Acad Dermatol. 2007 Sep;57(3):535. author reply 536.
  • Martinez MI, Sanchez-Carpintero I, North PE, et al. Infantile hemangioma: clinical resolution with 5 % imiquimod cream. Arch Dermatol. 2002;1387:881–884. discussion 884
  • Drolet BA, Frommelt PC, Chamlin SL, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;1311:128–140.
  • European Medicines Agency website. European Medicines Agency decision. http://www.ema.europa.eu/docs/en_GB/document_library/PIP_decision/WC500141483.pdf
  • Léauté-Labrèze C, Hoeger P, Mazereeuw-Hautier J, et al. A randomized, controlled trial of oral propanolol in infantile hemangioma. N Engl J Med. 2015 Feb 19;372(8):735–746.
  • Marqueling AL, Oza V, Frieden IJ, et al. Propanolol and infantile hemangiomas four years later: a systematic review. Pediatr Dermatol. 2013 Mar-Apr;30(2):182–191. DOI:10.1111/pde.12089.
  • Janmohamed SR, Madern GC, De Laat PC, et al. Educational paper: therapy of infantile haemangioma–history and current state (part II). Eur J Pediatr. 2015 Feb;174(2):259–266.
  • Dinehart SM, Kincannon J, Hemangiomas: GR. evolution and treatment. DermatolSurg. 2001 May;27(5):475–485.
  • World Health Organization. Estimates in saving newborn lives. Washington, DC: State of the World’s Newborns. Save the Children Federation-U.S. 2001; 1–49.
  • Admani S, Jinna S, Friedlander SF. Kids are not just little people. Clin Dermatol. 2015 Nov-Dec;33(6):657–671.
  • Rush J, Dinulos JG. Childhood skin and soft tissue infections: new discoveries and guidelines regarding the management of bacterial soft tissue infections, molluscum contagiosum, and warts. Curr Opin Pediatr. 2016 Apr;28(2):250–257. doi:10.1097/MOP.0000000000000334.
  • Sucato G, Wald A, Wakabayashi E, et al. Evidence of latency and reactivation of both herpes simplex virus (HSV)-1 and HSV-2 in the genital region. J Infect Dis. 1998 Apr;177(4):1069–1072.
  • Roberts S. Herpes simplex virus: incidence of neonatal herpes simplex virus, maternal screening, management during pregnancy, and HIV. Curr Opin Obstet Gynecol. 2009;21(2):124–130.
  • Wilson P, Sutton AG, Nassef C, et al. Persistent gaps in appropriate use of empiric acyclovir in neonates. Clin Pediatr (Phila). 2016 Dec 8;pii: 0009922816678975. [Epub ahead of print].
  • Kimberlin DW. Neonatal herpes simplex infection. Clin Microbiol Rev. 2004;17(1):1–13.
  • Kimberlin DW. Herpes simplex virus infections of the newborn. Semin Perinatol. 2007;31:19.
  • Kimberlin DW, Lin CY, Jacobs RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001 Aug;108(2):230–238.
  • American Academy of Pediatrics. Herpes simplex. In: Kimberlin DW, Brady MT, Jackson MA, et al. editors. Red Book: 2015 Report of the Committee on Infectious Diseases. 30th Elk Grove Village, IL: American Academy of Pediatrics; 2015: 432–445.
  • Ericson JE, Gostelow M, Autmizguine J, et al. Safety of high-dose acyclovir in infants with suspected and confirmed neonatal herpes simplex virus infections. Pediatr Infect Dis J. 2017 Apr;36(4):369–373.
  • De Paschale M, Clerici P. Microbiology laboratory and the management of mother-child varicella-zoster virus infection. World J Virol. 2016 Aug 12;5(3):97–124.
  • Royal Colege of Obstetricians and Ginaecologists. Chickenpox in Pregnancy: Green-top Guideline N.13. 2015. Available from: https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg13/.
  • Hersh AL, Chambers HF, Maselli JH, et al. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med. 2008;168:1585–1591.
  • Meddles-Torres C, Hu S, Jurgens C. Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus. J Infect Public Health. 2013 Dec;6(6):423–430. doi:10.1016/j.jiph.2013.04.010. Epub 2013 Jun 15.
  • Suaya JA, Mera RM, Cassidy A, et al. Incidence and cost of hospitalizations associated with Staphylococcus aureus skin and soft tissue infections in the United States from 2001 through 2009. BMC Infect Dis. 2014;14:296.
  • Brown J, Shriner DL, Schwartz RA, et al. Impetigo: an update. Int J Dermatol. 2003;42:251–255.
  • Pereira LB. Impetigo: review. Ann Bras Dermatol. 2014;89:293–299.
  • Del Giudice P, Hubiche P. Community-associated methicillin-resistant Staphylococcus aureus and impetigo. Br J Dermatol. 2010;162:905–906.
  • Koning S, van der Sande R, Verhagen AP, et al. Interventions for impetigo. Cochrane Database Syst Rev. 2012;1:CD003261.
  • Antonov NK, Garzon MC, Morel KD, et al. High prevalence of mupirocin resistance in Staphylococcus aureus isolates from a pediatric population. Antimicrob Agents Chemother. 2015;59:3350–3356.
  • Mullany LC, Darmstadt GL, Katz J, et al. Development of clinical sign based algorithms for community based assessment of omphalitis. Arch Dis Child Fetal Neonatal Ed. 2006;91(2):F99–104.
  • Stewart D, Benitz W, Committee on fetus and newborn. Umbilical Cord Care in the Newborn Infant. Pediatrics. 2016;138(3). pii: e20162149. doi:10.1542/peds.2016-2149.
  • Jamal N, Teach SJ. Necrotizing fasciitis. Pediatr Emerg Care. 2011;27(12):1195–1199.
  • Schiestl C. Management of septic skin necroses. Eur J Pediatr Surg. 2013;23(5):349–358.
  • Lyu X, Zhao C, Yan ZM, et al. Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis. Drug Des Devel Ther. 2016 Mar 16;10:1161–1171.
  • Akpan A, Morgan R. Oralcandidiasis. Postgrad Med J. 2002;78(922):455–459.
  • Pankhurst CL. Candidiasis (oropharyngeal). BMJ Clin Evid. 2013 Nov;8(2013):1304.
  • Buckley BS, Blas Mantaring J, Dofitas RB, et al. A new scale for assessing the severity of uncomplicated diaper dermatitis in infants: development and validation. Pediatric Dermatology. 2016;33(6):632–639.
  • Adalat S, Wall D, Goodyear H. Diaper dermatitis frequency and contributory factors in hospital attending children. Pediatr Dermatol. 2007;24:483–488.
  • Van Gysel D. Infections and skin diseases mimicking diaper dermatitis. Int J Dermatol. 2016 Jul;55(Suppl 1):10–13. Review. DOI:10.1111/ijd.13372
  • Bieber T. Atopic dermatitis. Ann Dermatol. 2010;22:125–137.
  • Hussain Z, Sahudin S, Thu HE, et al. Recent advances in pharmacotherapeutic paradigm of mild to recalcitrant atopic dermatitis. Crit Rev Ther Drug Carrier Syst. 2016;33(3):213–263.
  • Dhar S, Srinivas SM. Food allergy in atopic dermatitis. Indian J Dermatol. 2016 Nov-Dec;61(6):645–648.
  • Levy ML. Atopic dermatitis: understanding the disease and its management. Curr Med Res Opin. 2007;23:3091–3103.
  • Eichenfield LF, Tom WL, Berger TG, et al. Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies. J Am Acad Dermatol. 2014;71:116–132.
  • Sidbury R, Davis DM, Cohen DE, et al. Guidelines of care for the management of atopic dermatitis. J Am Acad Dermatol. 2014;71:327–349.
  • Horimukai K, Morita K, Narita M, et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol. 2014;134:824–830.
  • Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134:818–823.
  • Levy ML, Erythrodermas I, Disorders M. Neonatal and. Dermatology I, Eichenfield LF, Frieden IJ, et al. . . Eds London: Elsevier; 2014. 265.
  • Fraitag S, Bodemer C. Neonatal erythroderma. CurrOpinPediatr. 2010;22:438.
  • Ott H, Hütten M, Baron JM, et al. Neonatal and infantile erythrodermas. J Dtsch Dermatol Ges. 2008;6:1070.
  • Al-Dhalimi MA. Neonatal and infantile erythroderma: a clinical and follow-up study of 42 cases. J Dermatol. 2007;34:302.
  • Pruszkowski A, Bodemer C, Fraitag S, et al. Neonatal and infantile erythrodermas: a retrospective study of 51 patients. Arch Dermatol. 2000;136:875.
  • Chang SE, Choi JH, Koh JK. Congenital erythrodermic psoriasis. Br J Dermatol. 1999 Mar;140(3):538–539.
  • Madiraca D, Šitum M, Prkačin I, et al. Treatment Options for Pediatric Psoriasis. Acta Dermato Venerol Croat. 2016 Aug;24(3):175–180.
  • Sticherling M, Augustin M, Boehncke WH, et al. Therapy of psoriasis in childhood and adolescence - a German expert consensus. J Dtsch Dermatol Ges. 2011 Oct;9(10):815–823. doi:10.1111/j.1610-0387.2011.07668.x. Epub 2011 May 18.
  • Napolitano M, Megna M, Balato A, et al. Systemic treatment of pediatric psoriasis: a review. Dermatol Ther (Heidelb). 2016 Jun;6(2):125–142. doi:10.1007/s13555-016-0117-6. Epub 2016 Apr 16.
  • Broberg A, Faergemann J. Infantile seborrhoeic dermatitis and pityrosporum ovale. Br J Dermatol. 1989;120:359.
  • Cohen S. Should we treat infantile seborrhoeic dermatitis with topical antifungals or topical steroids? Arch Dis Child. 2004;89:288.
  • Eichenfield LF, Frieden IJ, Zaenglein A, et al. Neonatal dermatology. 2nd ed. Philadelphia: Saunders Elsevier; 2007.
  • Moin A, Farhoudi A, Moin M, et al. Cutaneous manifestations of primary immunodeficiency diseases in children. Iran J Allergy Asthma Immunol. 2006;5(3):121–126.
  • Jen M, Yan A. Syndromes associated with nutritional deficiency and excess. Clin Dermatol. 2010;28:668–669.
  • Wolf B. Biotinidase deficiency: “if you have to have an inherited metabolic disease, this is the one to have”. Genet Med. 2012;14(6):565–575.
  • Scheinfeld NS, Bhatia J. Biotin Deficiency Treatment & Management. http://emedicine.medscape.com/article/984803-treatment.
  • Lakdawala N, Grant-Kels JM. Acrodermatitis enteropathica and other nutritional diseases of the folds (intertriginous areas). ClinDermatol. 2015;33(4):414–419.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.